GlaxoSmithKline’s HIV PrEP challenge looms as ViiV’s long-acting drug tops Gilead’s Truvada in women aliu Mon, 11/09/2020 – […]
Researchers at the University of Colorado Boulder are developing a wearable electronic device that’s “really wearable”- a stretchy […]
In the quest to image exceedingly small structures and phenomenon with higher precision, scientists have been pushing the […]
The Independent Scientific Advisory Group for Emergencies (Independent SAGE) has renewed its call for urgent reform of the […]
The NHS should vary the price it pays for cancer drugs depending on the disease they are used […]
The National Institute for Health and Care Excellence (NICE) is proposing placing more emphasis on “real world evidence” […]
The title of Torjesen’s article, “BMA should drop its opposition to assisting dying, say members in landmark poll,”1 […]
ABSTRACTOvarian cancer is the third most common gynecologic malignancy worldwide but accounts for the highest mortality rate among […]
New approval marks third indication for an Opdivo plus Yervoy-based regimen in the EU
Industry bodies respond to Specialised Committee outcome